Tech Company Financing Transactions
Xtent Funding Round
Xtent, based in Menlo Park, scored $25 million from Morgenthaler Ventures, Advanced Technology Ventures and Latterell Venture Partners.
Transaction Overview
Company Name
Announced On
3/3/2005
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors
Morgenthaler Ventures (Lead Investor) (Robin Bellas)
Proceeds Purpose
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
125 Constitution Drive
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Xtent, Inc. (Nasdaq: XTNT) is a developer of stent systems for delivering multiple drug eluting stents of customizable length with a single catheter.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Casciaro
Chief Financial Officer
Timothy Kahlenberg
Chief Technical Officer
Randolph Campbell
VP - General Counsel
Jeffry Grainger
VP - Marketing
Brian Walsh
VP - R & D
Bernard Andreas
VP - Regulatory Affairs
Philippe Marco
Browse more venture capital transactions:
Prev: 3/2/2005: G2 SwitchWorks venture capital transaction
Next: 3/3/2005: Bio-Lok International venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs